rethinkTHC Search
Menu
Study breakdown

Large meta-analysis finds regular cannabis use raises both pro-inflammatory and anti-inflammatory markers, not just one or the other

Meta AnalysisStrong evidence
The takeaway

A meta-analysis of 46 studies found regular cannabinoid use associated with elevated levels of both pro- and anti-inflammatory biomarkers, suggesting immunomodulation rather than simple anti-inflammatory effects.

Immunology researchers, medical cannabis patients, inflammation-focused clinicians

54,382 participants; both pro- and anti-inflammatory markers elevated with cannabis use

What the researchers found

Cannabis use was associated with higher anti-inflammatory biomarkers (SMD = 0.298, PD = 99%) and pro-inflammatory biomarkers (SMD = 0.166, PD = 100%). CBD RCTs suggested small pro-inflammatory marker increases (SMD = 0.15, PD = 90.9%). No consistent effects in prospective studies. Results varied by demographics, study design, and recency of use.

Why it matters

Cannabis is widely described as "anti-inflammatory," but this meta-analysis shows regular use modulates the immune system in both directions simultaneously, with implications for people using cannabis to manage inflammatory conditions.

The numbers in context

46 studies, 54,382 participants, 190 effect sizes. Anti-inflammatory SMD = 0.298 (CrI 0.052-0.536). Pro-inflammatory SMD = 0.166 (CrI 0.122-0.209). CBD RCTs: pro-inflammatory SMD = 0.15. No major publication bias.

How the study worked

Systematic review and Bayesian multilevel meta-analysis of 46 studies (54,382 participants). 190 effect sizes pooled in three analyses. Bayesian hierarchical models accounted for clustering within studies and biomarkers.

What this study cannot tell us

Most evidence from cross-sectional studies. Only 2 prospective and 10 RCTs. Heterogeneity in cannabinoid type, dose, and duration across studies.

How to read the evidence

Large meta-analysis with advanced Bayesian methods, but predominantly cross-sectional evidence limits causal interpretation.

When this study was published

2026 publication with search through October 2025

The bigger picture

The "cannabis is anti-inflammatory" narrative oversimplifies a complex immunological picture. Cannabis acts as an immunomodulator, and the long-term consequences of dual modulation remain unknown.

Questions still open

  • Does dual pro/anti-inflammatory modulation benefit or harm people with autoimmune conditions? What are the long-term cardiovascular consequences?

Common questions

Is cannabis anti-inflammatory?
More accurately described as immunomodulatory. This meta-analysis found cannabis associated with increases in both anti-inflammatory and pro-inflammatory biomarkers.
Does CBD reduce inflammation?
RCT data in this meta-analysis suggested CBD may slightly increase pro-inflammatory markers. The assumption that CBD is purely anti-inflammatory may be an oversimplification.

Read the original research

Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.

Brain, behavior, and immunity, 106517

Citation

Murri, Martino Belvederi; Guglielmo, Riccardo; Zizzi, Alessio; Muscettola, Angela; Nanni, Maria Giulia; Dall'Oro, Manuela; Serafini, Gianluca; Inuggi, Alberto; Escelsior, Andrea; Amore, Mario; Grassi, Luigi. (2026). Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.. Brain, behavior, and immunity, 106517. https://doi.org/10.1016/j.bbi.2026.106517

Explore the wider topic